Biliary tract disease is a relatively uncommon, heterogenous disease in pregnancy. Specifical 
holelithiasis is a condition which effects approximately 20 million American women with million new cases diagnosed each year. Women of reproductive age are 4 times more likely than men of similar age to develop gallbladder disease, z Epidemiologic studies indicate that the incidence of cholesterol gallstones rises abruptly as women enter the childbearing years. 3 In fact, several studies show a direct relationship between parity and risk of developing biliary stones. [4] [5] [6] Generally though, biliary tract disease is a relatively uncommon occurrence during pregnancy. A recent review of more than 45,000 pregnant women revealed the incidence of symptomatic biliary tract disease to be 0.16% in pregnancy. 7 Despite its relatively uncommon occurrence during pregnancy, 81% of women with symptoms of gallbladder disease had their first attack within 1 year of pregnancy. Pregnancy then seems to predispose women to developing biliary tract disease.
Biliary tract disease encompasses a continuum of pathologic entities which includes biliary sludging, cholelithiasis, cholecystitis, choledocholithiasis, and cholangitis. Biliary sludge or the supersaturation of bile with cholesterol, is an important precursor to gallstone formation. The exact prevalence of cholelithiasis in pregnancy is essentially unknown since 50% of women with gallstones are asymptomatic. Efforts to identify asymptomatic cholelithiasis in pregnancy using ultrasound have produced variable results; however, the best estimate of incidence appears to be between 2.5% and 4.5%. 8-1o In addition to pregnancy, several other factors are strongly associated with gallbladder disease. Ethnicity contributes to the risk for developing biliary disease. In particular, 70% of Native American women older than 30 Pipcracillin, an extended spectrum penicillin, has broad coverage against all organisms commonly bound in the biliary tract, excellent biliary excretion, and negligible nephrotoxicity. It has also been shown to be efficacious in patients with acute cholecystitis, zz,z' The overall cure rate for acute cholecystitis in patients treated with piperacillin, ampicillin and tobramycin, or cefopcrazonc was 92% with no difference in any of the three groups, zz Hence, when considering antibiotic therapy in patients with acute cholecystitis, the standard of a penicillin and an aminoglycosidc remains an effective regimen. However, when considering more current issues such as cost containment, alternatives including extended spectrum penicillins or third generation cephalosporins cannot be ignored.
In managing acute cholecystitis in pregnancy, many physicians advocate initial non-operative management in an effort to prevent surgical intervention prior to completion of the pregnancy. The pregnancy outcomes are highly dependent on the trimester during which the biliary symptoms occur. One study evaluated 26 pregnant patients with acute cholecystitis in all three trimesters. Only 2 of the 7 patients who presented in the first trimester had pregnancies which went to term, whereas all patients who presented in the third trimester completed a successful pregnancy, 
